Protagenic Therapeutics, Inc.\new Preferred Stock, Shares Authorized
Protagenic Therapeutics, Inc.\new (PTIX) had Preferred Stock, Shares Authorized of 2.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-19
- 2026-06-30: Preferred Stock, Shares Authorized 2.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 2.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 2.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 20.00M shares.
| Period end | Preferred Stock, Shares Authorized | Preferred Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 2.00M shares 10-Q · filed 2026-08-19 | |
| 2026-03-31 | 2.00M shares 10-Q · filed 2026-08-19 | |
| 2025-12-31 | 2.00M shares 10-Q · filed 2026-03-09 | |
| 2025-09-30 | 20.00M shares 10-Q · filed 2025-11-26 | |
| 2025-06-30 | 20.00M shares 10-QT · filed 2025-09-10 | |
| 2025-03-31 | 2.00M shares 10-K · filed 2026-08-14 | 20.00M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 20.00M shares 10-Q · filed 2025-05-13 | |
| 2024-09-30 | 20.00M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 20.00M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 20.00M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 20.00M shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 20.00M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 20.00M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 20.00M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 20.00M shares 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | 20.00M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 20.00M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 20.00M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 20.00M shares 10-K · filed 2023-03-31 | |
| 2021-09-30 | 20.00M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 20.00M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 20.00M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 20.00M shares 10-K · filed 2022-04-07 | |
| 2020-09-30 | 2.00M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 2.00M shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 2.00M shares 10-Q · filed 2020-06-18 | |
| 2019-12-31 | 20.00M shares 10-K · filed 2021-03-25 | 2.00M shares 10-K · filed 2020-04-29 |
| 2019-09-30 | 2.00M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 2.00M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 2.00M shares 10-Q · filed 2019-05-16 | |
| 2018-12-31 | 2.00M shares 10-K · filed 2020-04-29 | |
| 2018-09-30 | 2.00M shares 10-Q · filed 2018-11-08 | |
| 2018-06-30 | 2.00M shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 2.00M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 2.00M shares 10-K · filed 2019-03-29 | |
| 2017-09-30 | 2.00M shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 18.00M shares 10-Q · filed 2017-08-08 | |
| 2017-03-31 | 20.00M shares 10-Q · filed 2017-05-15 | |
| 2016-12-31 | 2.00M shares 10-K · filed 2018-04-02 | 20.00M shares 10-K · filed 2017-04-18 |
| 2016-09-30 | 20.00M shares 10-Q · filed 2016-11-17 | |
| 2016-07-27 | 20.00M shares 10-Q · filed 2016-11-17 | |
| 2016-06-27 | 20.00M shares 10-Q · filed 2016-11-17 | |
| 2016-06-26 | 5.00B shares 10-Q · filed 2016-11-17 | |
| 2016-02-12 | 20.00M shares 10-Q · filed 2016-07-25 | |
| 2015-12-31 | 20.00M shares 10-K/A · filed 2017-05-08 | 5.00B shares 10-Q · filed 2016-03-11 |
| 2015-09-30 | 5.00B shares 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 5.00B shares 10-Q · filed 2016-03-11 | |
| 2015-03-31 | 5.00B shares 10-Q · filed 2015-05-11 | |
| 2014-06-30 | 5.00B shares 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |